Taking full advantage of the stock market and investing with confidence ... San Diego, CA.-based Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. At that time, the S&P 500 had slid by 0.9% and the Nasdaq Composite ...

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

Shares of Illumina Inc. ILMN shed 5.47% to $104.99 Monday, on what proved to be an all-around favorable trading session for ...

At the time of writing Illumina stock is trading 5.14% lower at $124.36, according to data from Benzinga Pro.

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded the stock to Sell and lowered the price target from $130 to $100. The firm cited several ...